— Know what they know.
Not Investment Advice

SWTX NASDAQ

SpringWorks Therapeutics, Inc.
1W: +0.0% 1M: +0.7% 3M: +12.2% 1Y: +24.7% 3Y: +76.1% 5Y: +5.5%
$46.99
Last traded 2025-07-02 — delisted
NASDAQ · Healthcare · Biotechnology · $3.5B mcap · 73M float · 7.70% daily turnover · Short 29% of daily vol

Balance Sheet Trends

Total Assets
$587M -19.1% ▼
5Y CAGR: +11.9%
Total Liabilities
$106M +6.6% ▲
5Y CAGR: +52.8%
Shareholders Equity
$481M -23.2% ▼
5Y CAGR: +8.4%
Cash & Investments
$308M -35.7% ▼
5Y CAGR: -1.2%
Total Debt
$8M +12.1% ▲
Net Debt
-$62M +63.4% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2020FY2021FY2022FY2023FY2024
— Assets —
Cash$147M$104M$67M$176M$70M
Short-Term Investments$361M$270M$525M$303M$238M
Cash & ST Investments$508M$374M$592M$479M$308M
Net Receivables$0$0$0$6M$46M
Inventory$0$0$0$3M$10M
Other Current Assets$0$9M$8M$13M$16M
Total Current Assets$513M$383M$600M$501M$380M
Property, Plant & Equip.$3M$4M$18M$24M$27M
Goodwill & Intangibles$0$0$0$11M$16M
Long-Term Investments$57M$62M$9M$185M$158M
Other Non-Current Assets$3M$3M$3M$4M$6M
Total Non-Current Assets$63M$70M$30M$225M$207M
Total Assets$576M$452M$630M$726M$587M
— Liabilities —
Accounts Payable$1M$3M$8M$7M$12M
Short-Term Debt$0$0$0$0$0
Deferred Revenue$0$0$3M$4M$0
Other Current Liabilities$0$0$20M$26M$0
Total Current Liabilities$18M$30M$51M$78M$100M
Long-Term Debt$0$0$0$0$0
Other Non-Current Liab.$164K$0$16M$15M$0
Total Non-Current Liabilities$2M$129K$21M$21M$6M
Total Liabilities$19M$30M$72M$100M$106M
— Equity —
Common Stock$5K$5K$6K$7K$7K
Retained Earnings-$119M-$293M-$570M-$895M-$1.2B
Accumulated OCI$41K-$312K-$767K$1M$304K
Total Stockholders Equity$557M$422M$558M$626M$481M
Total Liabilities & Equity$576M$452M$630M$726M$587M
— Key Metrics —
Total Debt$3M$1M$5M$7M$8M
Net Debt-$144M-$103M-$62M-$169M-$62M
Total Investments$419M$332M$534M$488M$396M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms